Greenberg Traurig’s David Dykeman and Robert Sherman to Present to Portugal Ventures
Share Article
Greenberg Traurig, LLP’s David J. Dykeman, patent attorney, co-chair of the firm’s Life Sciences & Medical Technology Practice, and co-managing shareholder of the Boston office, and Robert A. Sherman, senior counsel in the Litigation Practice and former United States Ambassador to Portugal, will present “IP Strategy for Early Stage Companies” to Portugal Ventures and its portfolio companies on April 21.
BOSTON (PRWEB)
April 21, 2021
Greenberg Traurig, LLP’s David J. Dykeman, patent attorney, co-chair of the firm’s Life Sciences & Medical Technology Practice, and co-managing shareholder of the Boston office, and Robert A. Sherman, senior counsel in the Litigation Practice and former United States Ambassador to Portugal, will present “IP Strategy for Early Stage Companies” to Portugal Ventures and its portfolio companies on April 21.